- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 41.83M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $115.83M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $31.02M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $196.55M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $319.74M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $37.15M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $49.13M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $57.29M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $49.45M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $57.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $317.81M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $355.92M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $333.77M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $369.97M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.55M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $22K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$19.1M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$252.5M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$225.72M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$17.89 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$17.89 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $4.93M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $22.65M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$27.8M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$27.58M |